Cheng et al52 found that hepatocellular cancer‐derived CAFs affect the survival, activation, and features of neutrophils in hepatocellular cancer via the IL6‐STAT3‐PDL1 signaling pathway. Here, CD274 is linked to hepatocellular carcinoma.